In vitro testing found that tedizolid reversibly inhibited MAO enzymes similarly to linezolid (80). A randomized, double-blind crossover trial of 30 healthy subjects assessed the pressor response to an oral tyramine challenge in patients treated with 200 mg of tedizolid. Seven subjects had a positive response of a 30 mm Hg increase in SBP during both placebo […]
Sign In